Cleared Traditional

K040913 - NGDI (NEXT GENERATION DIAGNOSTIC INSTRU...

K040913 is the FDA 510(k) clearance for NGDI (NEXT GENERATION DIAGNOSTIC INSTRU... by Bausch & Lomb. It is a Class 2 Ophthalmic device (product code MXK) cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K040913 · Bausch & Lomb · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2004
Decision
106d
Days
Class 2
Risk

K040913 is an FDA 510(k) clearance for the NGDI (NEXT GENERATION DIAGNOSTIC INSTRUMENT). Classified as Device, Analysis, Anterior Segment (product code MXK), Class II - Special Controls.

Submitted by Bausch & Lomb (San Dimas, US). The FDA issued a Cleared decision on July 23, 2004 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1850 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Bausch & Lomb devices

Submission Details

510(k) Number K040913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2004
Decision Date July 23, 2004
Days to Decision 106 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 110d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code MXK Device, Analysis, Anterior Segment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.